山海棠合剂治疗血热型寻常型银屑病疗效及对IL-12、IL-23的影响
本文选题:山海棠合剂 + 血热型 ; 参考:《云南中医学院》2017年硕士论文
【摘要】:目的:观察山海棠合剂治疗血热型寻常型银屑病的疗效及安全性,并从微观角度探讨药物作用机理,为山海棠合剂治疗寻常型银屑病的临床应用提供科学依据。方法:采用随机对照试验,把66例血热型寻常型银屑病患者随机分为试验组和对照组,每组33例,详细记录患者相关资料并检测血清IL-12和IL-23水平;同时选取30例健康志愿者检测血清IL-12和IL-23水平进行比较。试验组口服山海棠合剂,对照组口服阿维A胶囊;两组均外用丹皮酚软膏。每周复诊1次,连续用药8周后进行疗效判定并复查血清IL-12和IL-23水平。运用SPSS22.0软件对数据资料进行统计分析。结果:1.受试66例患者中,试验组脱落1例,对照组脱落3例,共收集有效病例62例。两组性别、年龄、病程、病情、血清IL-12和IL-23水平等基线资料具有可比性(P0.05)。2.疗程结束,试验组和对照组中医证候评分均较治疗前显著降低(P0.05),试验组优于对照组(P0.05)。3.疗程结束,试验组和对照组PASI评分均较治疗前显著降低(P0.05),两组比较差异无统计学意义(P0.05)。4.试验组和对照组治疗前血清IL-12和IL-23水平均显著高于健康志愿者(P0.05),疗程结束后均较治疗前显著降低(P0.05);疗程结束两组血清IL-12水平、试验组血清IL-23水平与健康志愿者比较差异无统计学意义(P0.05),对照组血清IL-23水平与健康志愿者比较差异仍有统计学意义(P0.05)。5.治疗7天后,试验组总有效率优于对照组(P0.05),治疗14天、21天、28天,两组总有效率比较差异无统计学意义(P0.05);疗程结束,试验组总有效率90.63%,愈显率71.88%;对照组总有效率83.33%,愈显率60.33%。试验组高于对照组,但两组比较差异无统计学意义(P0.05)。6.试验组和对照组均无严重不良反应发生,试验组有3例发生轻度腹痛、腹胀,减少服药次数后症状消失;对照组有6例服药后出现皮肤干燥、口腔黏膜干燥,未经处理,随用药时间推移自行缓解,3例服药期间出现转氨酶轻度升高,停药2个月后复查恢复至正常。7.疗程结束后随访3个月,试验组复发4例,对照组复发9例,两组比较差异有统计学意义(P0.05)。结论:山海棠合剂治疗血热型寻常型银屑病疗效确切,无明显不良反应,与西药阿维A胶囊相比具有起效较快、复发率低、不良反应较轻等优势。
[Abstract]:Objective: to observe the efficacy and safety of Shanhaitang mixture in treating psoriasis vulgaris with blood heat, and to explore the mechanism of drug action from microscopic point of view, and to provide scientific basis for clinical application of Shanhaitang mixture in the treatment of psoriasis vulgaris. Methods: 66 patients with psoriasis vulgaris of blood fever type were randomly divided into trial group and control group with 33 cases in each group. The relevant data and serum IL-12 and IL-23 levels were recorded in detail. Serum IL-12 and IL-23 levels were measured in 30 healthy volunteers. The experimental group was treated with Shanhaitang mixture and the control group with Avera capsule, and both groups were treated with paeonol ointment. The curative effect was evaluated and the serum IL-12 and IL-23 levels were reviewed after 8 weeks of continuous treatment. Use SPSS22.0 software to carry on the statistical analysis to the data. The result is 1: 1. Among 66 patients, 1 case in the test group and 3 cases in the control group. 62 effective cases were collected. The baseline data of sex, age, course of disease, condition, serum IL-12 and IL-23 levels were comparable between the two groups. At the end of the course of treatment, the scores of TCM syndromes in the test group and the control group were significantly lower than those before treatment, and the test group was superior to the control group. At the end of the course of treatment, the PASI scores of the test group and the control group were significantly lower than those of the control group before treatment. The difference between the two groups was not statistically significant. The levels of serum IL-12 and IL-23 in the experimental group and the control group were significantly higher than those in the healthy volunteers before treatment, and the levels of serum IL-12 in the two groups were significantly lower after the end of the course of treatment than before the treatment, and at the end of the course of treatment, the levels of serum IL-12 in the two groups were significantly decreased. There was no significant difference in serum IL-23 level between the experimental group and the healthy volunteers, but there was still significant difference in the serum IL-23 level between the control group and the healthy volunteers. After 7 days of treatment, the total effective rate in the experimental group was better than that in the control group (P 0.05), the total effective rate in the two groups was not significantly different from that in the control group (P 0.05), the total effective rate in the test group was 90.63 and 71.888.The total effective rate in the control group was 83.33 and the effective rate was 60.33. The experimental group was higher than the control group, but there was no significant difference between the two groups. There were 3 cases of mild abdominal pain and abdominal distention in the test group, and 6 cases of the control group had dry skin, dry oral mucosa and untreated skin after reducing the number of times of taking the medicine, and no serious adverse reactions occurred in the test group and control group, while in the control group, there were 3 cases with mild abdominal pain and abdominal distension. The level of transaminase increased slightly in 3 patients with spontaneous remission during medication, and returned to normal at 2 months after withdrawal. Three months after the end of the course of treatment, 4 cases of recurrence were found in the trial group and 9 cases in the control group. The difference between the two groups was statistically significant (P 0.05). Conclusion: Shanhaitang mixture is effective in treating psoriasis vulgaris of blood fever type and has no obvious adverse reaction. Compared with Avea capsule, it has the advantages of quick onset, low recurrence rate and mild adverse reaction.
【学位授予单位】:云南中医学院
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R275.9
【参考文献】
相关期刊论文 前10条
1 陈春凤;郑益志;贾丽莹;余土根;;舒肝解郁胶囊治疗寻常型银屑病的临床研究[J];中国临床药理学杂志;2017年03期
2 唐艳;梁虹;;NB-UVB不同照射方案治疗中重度银屑病疗效比较[J];现代仪器与医疗;2017年01期
3 胡志帮;刁庆春;;不同剂量308nm准分子光治疗斑块状银屑病疗效分析[J];重庆医学;2017年03期
4 吴波;程孝顶;曲善忠;蒋存火;;自血疗法配合穴位埋线治疗寻常型银屑病90例疗效观察[J];四川医学;2017年01期
5 张翠侠;翟晓翔;尹新江;孟飒;陈桂升;;火针联合308nm准分子激光治疗斑块型银屑病50例[J];福建中医药;2016年06期
6 吴科佳;;润燥止痒胶囊联合NB-UVB治疗寻常性银屑病血虚风燥证29例临床观察[J];中国皮肤性病学杂志;2016年12期
7 徐平;丁佩军;张慧敏;;狼毒方熏洗联合复方青黛胶囊口服治疗寻常型银屑病血热证31例临床观察[J];中医杂志;2016年22期
8 廖清;;积极心理治疗对银屑病患者心理状况及行为的影响[J];实用中医药杂志;2016年11期
9 李静;吴佳纹;肖生祥;王媛;郭坤;邹四新;周静;陈曼曼;;银屑病患者血清免疫球蛋白E水平检测及其临床意义[J];陕西医学杂志;2016年11期
10 符文好;刘军麟;肖传柳;彭程;罗杨;;影响寻常型银屑病预后复发的危险因素调查分析[J];中国卫生统计;2016年05期
相关硕士学位论文 前3条
1 周振兴;银屑病患者血液学检验指标变化特点及其对临床诊治价值的研究[D];中国人民解放军军事医学科学院;2013年
2 杨晓蕾;昆明山海棠提取物对EGF诱导的血管平滑肌细胞增殖及原癌基因c-jun mRNA表达的影响[D];昆明医科大学;2013年
3 陈妍;昆明山海棠提取物对人血管内皮及血管平滑肌细胞增殖的影响[D];昆明医科大学;2012年
,本文编号:1958331
本文链接:https://www.wllwen.com/zhongyixuelunwen/1958331.html